Novel Viral Vaccine Protects Aids In Animal Model

Research Triangle Park, N.C., Nov. 11, 1998 -- BioStratum Incorporated announced today that its proprietary gene-attenuated virus vaccine candidates prevent the development of AIDS in monkeys. The report, published in the November Journal of Virology, documents the efficacy of two gene-attenuated virus vaccines that protect macaque monkeys against exposure to an HIV-1- based virus that produces AIDS. Opendra ("Bill") Narayan, Ph.D., D.V.M., director of the Marion Merrell Dow Laboratory of Viral Pathogenesis at the University of Kansas Medical Center, conducted the study.

BioStratum also announced today the formation of a new subsidiary, TheraVax Incorporated, to expand current development efforts for a novel treatment for HIV infections that consists of a viral vaccine administered in combination with anti-HIV drugs. The goal of this new therapy will be to reduce or eliminate the need for continued drug cocktail therapy. All HIV-related technology currently licensed from the University of Kansas Medical Center to BioStratum, including a proprietary HIV-1-based AIDS animal model and the candidate gene-attenuated virus vaccines, will be transferred to TheraVax for development and commercialization.

"With more people living with HIV infection, the need is great for an affordable, effective treatment such as a therapeutic vaccine that does not have the harmful side effects of the current anti-HIV drug therapies," says Archie Prestayko, Ph.D., president and chief executive officer of BioStratum.

In the Journal of Virology study, Narayan and his colleagues tested the protective effects of the viral vaccines by exposing the immunized monkeys to a highly pathogenic hybrid virus named KU-SHIV-1, which Narayan developed three years ago. KU-SHIV-1's inner structure is derived from SIV (simian immunodeficiency virus) and the virus' outer surface, or envelope, is derived from HIV-1 (human immunodeficiency virus). The compos

Contact: Anjani Shah, Ph.D.
212-696-4455 x.340
Noonan/Russo Communications

Page: 1 2 3

Related biology news :

1. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
2. Novel therapeutic bortezomib moves to phase II trial in lung cancer patients
3. Novel approaches to current cellular therapies continue progress toward disease prevention
4. Novel therapies show promise against myeloid leukemia
5. Novel sensors help clear the air
6. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
7. Novel proteins designed that block inflammation regulator associated with rheumatoid arthritis
8. Novel therapeutic target identified in fight against Rheumatoid Arthritis
9. Novel bacterium detoxifies chlorinated pollutants
10. Novel flu vaccine shows promise in mice
11. Novel gene therapy on the horizon, says Brenner Childrens Hospital pediatrician

Post Your Comments:

(Date:6/27/2019)... IRVINE, Calif. (PRWEB) , ... June 27, 2019 , ... ... from the Illuminating Energy Society (IES), which honored the designers for creating both engaging ... area of 701B Street , an office tower in San Diego, California earned ...
(Date:6/19/2019)... ... June 19, 2019 , ... Dahryn Trivedi, today released research results ... Sodium, antibiotic which can prove to be beneficial for treating multiple bacterial diseases. , ... amount , Over 68% decrease in weight , Over ...
(Date:6/14/2019)... ... , ... Molecular diagnostics segment is the fastest-growing segment within the global IVD ... segments that are expected to drive the growth are infectious diseases, cancer, and transplant ... Kalorama’s The World Molecular Diagnostics Market, 8th Edition . , The discovery of ...
Breaking Biology News(10 mins):
(Date:6/26/2019)... , ... June 26, 2019 , ... Alice Branton today ... on improving physicochemical properties of Magnesium Gluconate, which can prove to be beneficial for ... alteration of characteristic differentiation peak, change in crystallite size , Over 142% ...
(Date:6/11/2019)... (PRWEB) , ... June 10, 2019 , ... ... of its distribution network with the appointment of Biofeedback Tech Ltd ... monitoring systems are an essential part of many therapeutic treatments and clinical assessment ...
(Date:6/11/2019)... Calif. (PRWEB) , ... June 11, 2019 , ... ... company of Personalized Stem Cells Inc. (PSC) , has announced that their ... Public Health, Food and Drug Branch for manufacturing. This is an important ...
(Date:5/31/2019)... Redwood City, California (PRWEB) , ... ... ... received allowance of our patent applications from the USPTO providing proprietary interest ... SYSTEM AND METHOD FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP ...
Breaking Biology Technology:
Cached News: